학술논문

Subcutaneous Trastuzumab Combined with Pertuzumab and Docetaxel as First-line Treatment of Advanced HER2-positive Breast Cancer
Document Type
Journal
Source
ANTICANCER RESEARCH; NOV 2018, 38 11, p6565-p6569, 5p.
Subject
Language
English
ISSN
17917530